Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
ACADIA Pharmaceuticals Inc. Stock Price (Quote) NASDAQ:ACAD
$17.51 ( -1.74% ) Friday, 15th Oct 2021
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $15.70 | $18.34 | Friday, 15th Oct 2021 ACAD stock ended at $17.51. This is 1.74% less than the trading day before Thursday, 14th Oct 2021. During the day the stock fluctuated 5.04% from a day low at $17.46 to a day high of $18.34. |
| 90 days | $15.68 | $24.36 | |
| 52 weeks | $15.68 | $57.46 |
Historical ACADIA Pharmaceuticals Inc. prices
| Date | Open | High | Low | Close | Volume |
| 2021-10-15 | $17.98 | $18.34 | $17.46 | $17.51 | 4 157 423 |
| 2021-10-14 | $17.41 | $17.84 | $16.64 | $17.82 | 2 797 039 |
| 2021-10-13 | $17.52 | $18.22 | $17.52 | $17.84 | 1 004 527 |
| 2021-10-12 | $17.31 | $17.90 | $17.31 | $17.63 | 966 276 |
| 2021-10-11 | $16.94 | $17.59 | $16.83 | $17.40 | 630 452 |
| 2021-10-08 | $17.25 | $17.25 | $16.87 | $16.93 | 534 766 |
| 2021-10-07 | $16.85 | $17.34 | $16.79 | $17.06 | 571 143 |
| 2021-10-06 | $16.74 | $17.09 | $16.71 | $16.87 | 566 046 |
| 2021-10-05 | $16.74 | $17.32 | $16.55 | $16.92 | 734 308 |
| 2021-10-04 | $17.38 | $17.55 | $16.65 | $16.79 | 996 683 |
| 2021-10-01 | $16.57 | $17.56 | $16.57 | $17.48 | 1 095 175 |
| 2021-09-30 | $17.00 | $17.18 | $16.54 | $16.61 | 1 049 572 |
| 2021-09-29 | $17.36 | $17.50 | $16.89 | $16.96 | 1 437 797 |
| 2021-09-28 | $17.24 | $17.99 | $17.18 | $17.27 | 1 967 939 |
| 2021-09-27 | $16.92 | $17.69 | $16.82 | $17.41 | 841 167 |
| 2021-09-24 | $17.28 | $17.42 | $16.94 | $16.94 | 703 008 |
| 2021-09-23 | $17.00 | $17.52 | $16.89 | $17.37 | 1 534 563 |
| 2021-09-22 | $17.01 | $17.18 | $16.68 | $17.04 | 922 481 |
| 2021-09-21 | $16.75 | $17.32 | $16.61 | $17.02 | 1 228 480 |
| 2021-09-20 | $16.39 | $16.88 | $16.16 | $16.71 | 1 330 623 |
| 2021-09-17 | $16.16 | $16.77 | $16.03 | $16.70 | 3 286 751 |
| 2021-09-16 | $15.92 | $16.13 | $15.71 | $16.12 | 858 301 |
| 2021-09-15 | $15.75 | $16.31 | $15.70 | $15.90 | 1 291 062 |
| 2021-09-14 | $16.33 | $16.45 | $15.68 | $15.78 | 1 807 580 |
| 2021-09-13 | $16.10 | $16.62 | $15.92 | $16.26 | 1 162 223 |
| 2021-09-10 | $16.47 | $16.49 | $16.08 | $16.09 | 963 847 |
| 2021-09-09 | $16.43 | $16.79 | $16.35 | $16.45 | 1 210 620 |
| 2021-09-08 | $16.42 | $16.55 | $16.00 | $16.53 | 1 194 345 |
| 2021-09-07 | $16.68 | $16.92 | $16.18 | $16.28 | 1 835 710 |
| 2021-09-03 | $17.17 | $17.22 | $16.70 | $16.78 | 1 152 007 |
| 2021-09-02 | $17.55 | $17.77 | $17.05 | $17.17 | 1 350 847 |
| 2021-09-01 | $17.53 | $17.87 | $17.36 | $17.69 | 893 995 |
| 2021-08-31 | $16.97 | $17.53 | $16.93 | $17.51 | 1 189 145 |
| 2021-08-30 | $17.22 | $17.36 | $16.83 | $16.97 | 714 388 |
| 2021-08-27 | $16.68 | $17.38 | $16.44 | $17.11 | 1 175 525 |
| 2021-08-26 | $17.16 | $17.31 | $16.63 | $16.68 | 850 667 |
| 2021-08-25 | $16.90 | $17.42 | $16.77 | $17.18 | 1 075 920 |
| 2021-08-24 | $17.05 | $17.07 | $16.63 | $17.00 | 971 553 |
| 2021-08-23 | $16.85 | $17.12 | $16.71 | $17.00 | 1 390 436 |
| 2021-08-20 | $16.09 | $16.78 | $16.09 | $16.68 | 1 212 268 |
| 2021-08-19 | $16.62 | $16.79 | $16.00 | $16.14 | 1 447 176 |
| 2021-08-18 | $17.32 | $17.52 | $16.69 | $16.72 | 1 562 166 |
| 2021-08-17 | $16.63 | $17.32 | $16.51 | $17.24 | 1 389 128 |
| 2021-08-16 | $17.50 | $17.50 | $16.79 | $16.84 | 1 111 110 |
| 2021-08-13 | $18.09 | $18.25 | $17.54 | $17.58 | 753 257 |
| 2021-08-12 | $18.30 | $18.40 | $17.68 | $18.04 | 1 137 350 |
| 2021-08-11 | $18.58 | $18.68 | $18.27 | $18.33 | 871 668 |
| 2021-08-10 | $19.12 | $19.19 | $18.23 | $18.49 | 1 482 446 |
| 2021-08-09 | $19.29 | $19.83 | $18.94 | $19.16 | 2 002 431 |
| 2021-08-06 | $19.24 | $19.56 | $18.91 | $19.18 | 2 311 071 |
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. Its lead product candidate, NUPLAZID, has completed the Phase III pivotal trials for the treatment of Parkinsons disease psychosis and the Phase II trial for the treatment of schizophrenia, as well as is in Phase II study for the treatment of Alzh... Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
Join 95.000+ Happy Subscribers
Don't miss out on the runners!
![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
